novo nordisk cagrilintide vs Retatrutide Compared Novo Nordisk's next-gen obesity drug

Medical professionals and researchers will find comprehensive analysis of the peptide's cellular pathways, pharmacokinetic properties, and translational considerations for clinical practice

A key conversation that got me thinking about writing this post was when Stuart Schreiber pointed out to me that the cinchona tree spent millions of years developing quinine as a highly optimized defense against something, and that something was certainly not PrP

Historically, mean weight loss has been modest with AOMs although with newer agents and combination therapy, higher degrees of weight loss can be achieved

Inhibition of HSP70 in endothelial cells in vitro suppresses their proliferation, migration, and vessel formation (Pinto-Martinez et al., 2026)

Research from Russia and Eastern Europe, where DSIP has been studied more extensively than in the United States, has suggested the peptide may reduce withdrawal symptom severity and improve outcomes in opioid detoxification protocols